Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial
2020 ◽
1998 ◽
Vol 114
(5)
◽
pp. 988-995
◽
2010 ◽
Vol 91
(10)
◽
pp. e37